J01XA05 oritavancin
ATC group of level 5 – chemical substance · in plain English: antibiotics
This site has the patient leaflet or the SPC of 3 medicines in this group.
- 2 prescription only (POM)
Active substance: Oritavancin – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J01 Antibacterials for systemic use 668 medicines
- J01X Other antibacterials 110 medicines
- J01XA Glycopeptide antibacterials 28 medicines
- J01XA05 oritavancin 3 medicines
- J01XA Glycopeptide antibacterials 28 medicines
- J01X Other antibacterials 110 medicines
- J01 Antibacterials for systemic use 668 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Orbactiv 400 mg powder for concentrate for solution for infusion SPC | Prescription only (POM) |
| Tenkasi (previously Orbactiv) SPC | – |
| Tenkasi 1200 mg powder for concentrate for solution for infusion SPC | Prescription only (POM) |
Other groups of the same level
- J01XA01 vancomycin 7 medicines
- J01XA02 teicoplanin 13 medicines
- J01XA03 telavancin 1 medicine
- J01XA04 dalbavancin 4 medicines
Other names of the ATC group
- Czech: J01XA05 Oritavancin
- French: J01XA05 oritavancine
- German: J01XA05 Oritavancin
- German: J01XA05 Oritavancin
- Polish: J01XA05 ORITAWANCYNA
- Turkish: J01XA05 oritavancin
- Portuguese (Brazil): J01XA05 Oritavancina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J01XA05
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.